Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis

Davide Bolignano, Graziella D’Arrigo, Anna Pisano and Giuseppe Coppolino

PLOS ONE, 2015, vol. 10, issue 8, 1-16

Abstract: Background: Pentoxifylline (PTX) is a promising therapeutic approach for reducing inflammation and improving anemia associated to various systemic disorders. However, whether this agent may be helpful for anemia management also in CKD patients is still object of debate. Study Design: Systematic review and meta-analysis. Population: Adults with CKD (any KDOQI stage, including ESKD patients on regular dialysis) and anemia (Hb

Date: 2015
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0134104 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 34104&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0134104

DOI: 10.1371/journal.pone.0134104

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().